Wegovy, Ozempic, and Mounjaro are remarkably effective for weight loss. But like all forms of weight loss, there is an important caveat: some of what you lose may be muscle mass — not just fat. This surprises many users and is something research is only beginning to fully understand.
In this article we explain what actually happens to your muscles during GLP-1 treatment, what the latest studies show, and what you can do to protect yourself.
What happens to muscles during weight loss?
When you lose weight — by any method — you always lose a mix of fat and muscle mass. This is normal. The body cannot exclusively burn fat. The question is how large a proportion comes from muscle, and whether it can be minimised.
With traditional calorie restriction (diet alone), typically 20–30% of weight loss comes from lean mass (muscle, bone, water). With GLP-1 medications — which produce larger and faster weight loss — the picture is somewhat more complex.
What does the research show?
Studies indicate that the proportion of muscle loss varies depending on which medication you take:
- Semaglutide (Wegovy/Ozempic): In the SEMALEAN study, participants lost an average of approximately 3 kg of lean mass over the first 7 months — but muscle loss stabilised thereafter. Grip strength (a measure of muscle function) actually improved by an average of +4.5 kg by month 12, suggesting that muscle quality can improve even during treatment.
- Tirzepatide (Mounjaro): In the SURMOUNT-1 trial, participants lost an average of 5.67 kg of lean mass out of a total weight loss of 22.1 kg — roughly 26% of total weight lost. A 2025 systematic review confirmed that tirzepatide appears to preserve a relatively greater proportion of lean mass compared to semaglutide.
Overall, research suggests that 25–45% of total weight loss with GLP-1 medications may come from lean mass, depending on diet, exercise, and the specific medication used.
Why is preserving muscle mass important?
Muscle mass is not just about appearance or strength. It matters for your overall health — now and in the future:
- Metabolism: Muscles burn energy even at rest. If you lose too much muscle, your resting metabolic rate drops, making it harder to maintain your weight if you stop the medication.
- Insulin sensitivity: Muscles are the body's primary engine for burning blood sugar. More muscle mass means better blood sugar control.
- Strength and function: Especially for older adults, muscle mass is critical for balance, mobility, and the ability to manage daily life independently.
- Bone health: Strength training and muscle loading protect bones against brittleness (osteoporosis).
Protein: the key nutrient for muscle preservation
The most important nutritional step to preserve muscle mass during weight loss is eating enough protein. Many people on GLP-1 medications experience a markedly reduced appetite — and risk eating too little protein even when eating as much as they can manage.
Most experts and clinical guidelines recommend:
- At least 1.2–1.6 g of protein per kg of body weight per day during active weight loss
- Spread protein evenly across 3–4 meals (20–40 g per meal)
- Prioritise protein-rich foods over carbohydrates when appetite is limited
Good protein sources include: eggs, chicken, fish, lean beef, dairy (Greek yogurt, cottage cheese), legumes, and tofu. Protein powder can supplement if it is difficult to meet requirements through food alone.
Quality matters: complete proteins (from animal sources or complementary plant protein combinations) contain all essential amino acids, including leucine — the most important trigger for muscle protein synthesis.
Resistance training: the other half of the solution
Protein alone is not enough. To preserve — and potentially build — muscle mass during weight loss, resistance training is essential. Aerobic exercise like walking and cycling is excellent for heart health, but only strength training effectively stimulates muscles to maintain their mass.
Recommendations from WHO and clinical experts:
- 2–3 resistance training sessions per week covering all major muscle groups
- Use free weights, machines, or bodyweight exercises (squats, lunges, push-ups)
- Progressive overload: gradually increase weight or repetitions over time
- Even 20–30 minutes per session has documented benefits
Studies show that combining GLP-1 medication with a high-protein diet and resistance training produces the best outcome: more fat loss, less muscle loss, and better long-term weight maintenance.
Signs you may be losing too much muscle
Muscle loss can be difficult to notice directly — the scale drops regardless. But watch out for these signs:
- You feel weaker in daily activities (climbing stairs, carrying shopping)
- You fatigue quickly during light physical activity
- Your grip strength (e.g. opening lids) is noticeably weaker than before
- You are losing weight rapidly, but your body feels "soft" rather than toned
Talk to your doctor if you are concerned. A bioimpedance analysis (body composition scan) can give a precise picture of what you are losing.
Is tirzepatide better for muscles than semaglutide?
Research suggests that tirzepatide (Mounjaro) may preserve a slightly higher proportion of muscle mass than semaglutide (Wegovy/Ozempic) during weight loss. This is likely because tirzepatide also activates the GIP receptor — in addition to the GLP-1 receptor — which appears to have a positive effect on muscle composition.
However, the difference is not dramatic, and diet and exercise are far more important factors in practice. This alone is not a reason to choose one medication over the other — discuss it with your doctor based on your overall health profile.
Practical tips — a summary
- Eat at least 1.2 g of protein per kg of body weight daily — prioritise protein at every meal
- Strength train 2–3 times per week, even with short sessions
- Avoid eating too little — an excessive calorie deficit accelerates muscle loss
- Get enough sleep — sleep is critical for muscle repair and hormonal balance
- Consider a body composition scan to track your progress
Sources
- Rondanelli M et al. — SEMALEAN: Impact of Semaglutide on fat mass, lean mass and muscle function in obesity. PMC, 2025
- Tirzepatide and muscle composition changes — SURPASS-3 MRI. The Lancet Diabetes & Endocrinology, 2025
- Effects of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Review. PMC, 2025
- Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists. PubMed, 2025
- New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? PubMed, 2025